Biogen Inc Said On Monday It Will Buy Nightstar Therapeutics Plc For About $800 Million

How To Get Started Making Money Today!

Biogen Inc said on Monday it will buy Nightstar Therapeutics Plc for about $800 million in cash as the company looks to tap into a potentially lucrative gene therapy market.

Biogen’s offer of $25.50 per share, represents a premium of 68 percent to Nightstar’s Friday close of $15.16.

Gene therapy, an emerging field of biotechnology, uses specially engineered viruses, or viral vectors, to deliver genetic material into defective cells, in hopes of improving or potentially even curing an inherited condition.

London-based gene therapy company Nightstar is focused on adeno-associated virus (AAV) treatments for inherited retinal disorders.

Freshdrop – The Domain Search Engine – Ever wondered how to get expired domains and earn $$$? – With FreshDrop it’s easier than ever!

“Ophthalmology is an emerging growth area for Biogen,” said Michel Vounatsos, Biogen’s chief executive officer. “Nightstar would accelerate our entry into ophthalmology by contributing two mid- to late-stage gene therapy assets.”

Biogen said it plans to fund the acquisition through available cash. Last week, Sarepta Therapeutics Inc beefed up its gene therapy portfolio through the purchase of its partner Myonexus Therapeutics Inc, while Swiss drugmaker Roche Holding AG said it was buying U.S.-based gene therapy specialist Spark Therapeutics Inc for $4.3 billion.

Goldman Sachs & Co is acting as financial adviser to Biogen and Centerview Partners was Nightstar’s financial adviser.

How To Get Started Making Money Today!


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.